Canine Cancer Alliance shares the latest HSA research, immunotherapy and other emerging therapies and vet questions you can ask.
Delving into Hemangiosarcoma is an ongoing process, and every new bit of information can make a difference for you and your dog. Browse through our carefully selected materials, organized by media type, and take away new insights to support you along the way.
Canine Cancer Alliance shares the latest HSA research, immunotherapy and other emerging therapies and vet questions you can ask.
The WSAVA's Oncology Committee provides clinical resources for veterinary healthcare teams, including HSA Fast Facts here.
The WSAVA’s Oncology Committee provides latest resources and best practices in pet cancer care. Read their HSA Fast Facts for Pet Owners.
Brought to you by the CCA, this video provides an overview of where hemangiosarcoma research stands at the end of 2024.
Dr. Ettinger explains the double two-thirds rule for splenic masses, offering insights on identifying hemangiosarcoma and other conditions.
Dr. Diehl and Dr. Borgatti discuss key insights on signs, disease biology, treatment, and past, present, and future research.
Dr. Brooke Britton breaks down cutaneous hemangiosarcoma—what to look for, treatment options, and the chances of it coming back.
This webinar reviews clinical trial findings for various treatments and promising research directions focused on extending survival.
Dr. Chand Khanna shares three key messages of hope stemming from an ongoing clinical trial of dogs with ruptured splenic tumors.
Dr. Jaime Modiano shares 20 years of hemangiosarcoma research in an Ottertalk, exploring new treatments, diagnosis, and prevention.